Sk Biopharmaceuticals Co Ltd Strategic Asset Allocation Index
Sk Biopharmaceuticals Co Ltd strategic asset allocation index. Sk Biopharmaceuticals Co Ltd (326030) has a Strategic Asset Allocation Index of 5.7% as of June 2023. Strategic assets (PP&E of ₩16.49 Billion plus long-term investments of ₩-) total ₩16.49 Billion, measured against net assets of ₩291.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible equity quality of Sk Biopharmaceuticals Co Ltd to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sk Biopharmaceuticals Co Ltd (2016–2022)
Strategic asset allocation index of Sk Biopharmaceuticals Co Ltd from 2016 to 2022. This chart shows how Sk Biopharmaceuticals Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2022. As of June 2023, the index stands at 5.7%, representing strategic assets of ₩16.49 Billion against net assets of ₩291.73 Billion KRW.
Sk Biopharmaceuticals Co Ltd Strategic Asset Allocation Index by Year (2016–2022)
Sk Biopharmaceuticals Co Ltd strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Sk Biopharmaceuticals Co Ltd from 2016 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 326030 market cap overview.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.4% | ₩20.35 Billion | ₩20.35 Billion | ₩- | ₩316.56 Billion | ▲ +1.3 pp |
| 2021 | 5.2% | ₩22.94 Billion | ₩22.94 Billion | ₩- | ₩444.19 Billion | ▼ -1.2 pp |
| 2020 | 6.4% | ₩24.23 Billion | ₩24.23 Billion | ₩- | ₩379.07 Billion | ▼ -14.3 pp |
| 2018 | 20.7% | ₩12.15 Billion | ₩12.15 Billion | ₩- | ₩58.63 Billion | ▼ -8.5 pp |
| 2017 | 29.3% | ₩13.82 Billion | ₩13.82 Billion | ₩- | ₩47.24 Billion | ▲ +18.5 pp |
| 2016 | 10.8% | ₩15.95 Billion | ₩15.95 Billion | ₩- | ₩147.69 Billion | — |